Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Bodei

Showing results (121-130 of 184) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitisElena Lazzeri, Ernest K J Pauwels, Paola A Erba, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2016
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Frontiers in Oncology|September 6, 2014
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveMarta Cremonesi, Carlo Chiesa, Lidia Strigari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Surgery|October 13, 2015
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategiesIrvin M Modlin, Andrea Frilling, Ronald R Salem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDik J Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomasLisa Bodei, Leo J Hofland, Diego Ferone, et al.
Pageof 19

Showing results (121-130 of 184) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|October 3, 2014
Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factorsLisa Bodei, Mark Kidd, Giovanni Paganelli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 6, 2011
Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II studyLisa Bodei, Marta Cremonesi, Chiara M Grana, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 9, 2004
Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitisElena Lazzeri, Ernest K J Pauwels, Paola A Erba, et al.
Journal of Thoracic Disease|December 5, 2017
Molecular strategies in the management of bronchopulmonary and thymic neuroendocrine neoplasmsIrvin M Modlin, Mark Kidd, Pier-Luigi Filosso, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 4, 2016
Erratum to: Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Frontiers in Oncology|September 6, 2014
Radioembolization of hepatic lesions from a radiobiology and dosimetric perspectiveMarta Cremonesi, Carlo Chiesa, Lidia Strigari, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2016
Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with <sup>177</sup>Lu-D OTATATEMaddalena Sansovini, Stefano Severi, Annarita Ianniello, et al.
Surgery|October 13, 2015
Blood measurement of neuroendocrine gene transcripts defines the effectiveness of operative resection and ablation strategiesIrvin M Modlin, Andrea Frilling, Ronald R Salem, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 18, 2005
Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogsDik J Kwekkeboom, Jan Mueller-Brand, Giovanni Paganelli, et al.
Cancer Biotherapy & Radiopharmaceuticals|February 19, 2004
In vivo and in vitro detection of dopamine d2 receptors in uveal melanomasLisa Bodei, Leo J Hofland, Diego Ferone, et al.
Pageof 19